Skip to content
Study details
Enrolling now

Transcranial Alternating Current Stimulation (tACS) for Anxiety in Veterans

Birmingham VA Health Care System
NCT IDNCT07288008ClinicalTrials.gov data as of Apr 2026
Target enrollment

40

Study length

about 2.5 years

Ages

19–70

Locations

1 site in AL

What this study is about

This trial is testing a wearable brain stimulation device to treat anxiety. The treatment involves using tACS, which delivers low-intensity pulsed alternating current via scalp electrodes. Up to 40 veterans with clinically significant anxiety will use the device at home for 8 weeks.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Transcranial alternating current stimulator

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Generalized Anxiety Disorder 7-item (GAD-7)

Secondary: Patient Health Questionnaire for Depression (PHQ-9)

Devices

therapeutic

Body systems

Psychiatry / Mental Health